ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 571,88
-0,80%
Dow Jones
40 211,72
0,00%
DAX
18 495,98
-0,56%
Brent Oil
83,065
-1,51%
Bitcoin
63 656,36
-1,84%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
07/03/200716h51Business WireInsmed Announces Restructure, Settlement Ending IPLEX(TM) Patent DisputeNASDAQ:INSMInsmed Inc
07/03/200705h24Business WireInsmed to Discuss Litigation Settlement with TercicaNASDAQ:INSMInsmed Inc
07/03/200701h18Business WireLitigation Settlement Reached Between Tercica, Genentech and InsmedNASDAQ:INSMInsmed Inc
10/01/200715h00Business WireItalian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)NASDAQ:INSMInsmed Inc
11/12/200620h31Business WireStandard & Poor's Initiates Factual Stock Report Coverage on Insmed, Inc.Click here for Standard & Poor's Factual Stock Report CNASDAQ:INSMInsmed Inc
07/12/200616h12Business WireInsmed to Host Litigation Update Conference CallNASDAQ:INSMInsmed Inc
07/12/200600h34Business WireInsmed Patent Litigation Verdict AnnouncedNASDAQ:INSMInsmed Inc
21/11/200614h15Business WireInsmed to Present at Upcoming Investor Conference in NYCNASDAQ:INSMInsmed Inc
03/11/200614h15Business WireInsmed Incorporated Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2006NASDAQ:INSMInsmed Inc
31/10/200622h17Business WireInsmed Inc. to Announce 2006 Third Quarter Financial ResultsNASDAQ:INSMInsmed Inc
31/10/200614h15Business WireJody LoMenzo Named Director, Investor Relations and Corporate CommunicationsNASDAQ:INSMInsmed Inc
30/10/200622h56Business WireInsmed to Present at Upcoming ConferencesNASDAQ:INSMInsmed Inc
25/10/200623h05Business WireFormer Amgen Manufacturing Executive Joins InsmedNASDAQ:INSMInsmed Inc
24/10/200614h15Business WireInsmed Announces Addition of Top 25 Patent Lawyer to Litigation TeamNASDAQ:INSMInsmed Inc
17/10/200622h15Business WireInsmed to Present at the BIO Investor Forum MeetingNASDAQ:INSMInsmed Inc
16/10/200622h15Business WireInsmed Sues Tercica for False AdvertisingNASDAQ:INSMInsmed Inc
05/10/200617h41PR Newswire (US)Insmed Provides Update Concerning Virginia Unfair Competition LitigationNASDAQ:INSMInsmed Inc
06/09/200614h13Business WireInsmed to Present at the BioCentury NewsMakers in the Biotech Industry ConferenceNASDAQ:INSMInsmed Inc
08/08/200622h03Business WireInsmed Incorporated Reports Financial Results for the First Half and Second Quarter Ended June 30, 2006NASDAQ:INSMInsmed Inc
07/08/200622h16Business WireInsmed Inc. to Webcast 2006 Second Quarter Financial Results Conference Call, Tuesday, August 8, 2006 at 4:30 p.m. (ET)NASDAQ:INSMInsmed Inc
31/07/200617h00PR Newswire (US)Phyton Biotech Signs Development Agreement With InsmedNASDAQ:INSMInsmed Inc
11/07/200614h19Business WireInsmed to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities ConferenceNASDAQ:INSMInsmed Inc
05/07/200620h15Business WireCourt Decision Means That Patent Dispute between Insmed and Tercica and Genentch Will Have to Be Resolved at TrialNASDAQ:INSMInsmed Inc
05/07/200615h15PR Newswire (US)European Medicines Agency Validates Insmed's Regulatory Application For Marketing IPLEX(TM) in EuropeNASDAQ:INSMInsmed Inc
27/06/200617h30Business WireInsmed Presents Positive IPLEX(TM) Data At ENDO 2006NASDAQ:INSMInsmed Inc
22/06/200614h04Business WireInsmed Endocrine Society 2006 Update; Insmed Will Report Efficacy of IPLEX(TM) in Patients with Severe Insulin Resistance; CompNASDAQ:INSMInsmed Inc
13/06/200614h04Business WireCourt Dismisses Baseless Unfair Business Practices Lawsuit That Was Brought Against InsmedNASDAQ:INSMInsmed Inc
09/06/200614h04Business WireInsmed Provides Update on IPLEX(TM) Launch; Company Shares Details on Payer Usage Program and PricingNASDAQ:INSMInsmed Inc
25/05/200614h05Business WireINSMED Announces IPLEX(TM) Availability Nationwide for Children with Severe Short Stature; IPLEX Launch Marked By The First ProNASDAQ:INSMInsmed Inc
12/05/200622h00Business WireInsmed Incorporated to Present at the Rodman & Renshaw 3rd Annual Healthcare ConferenceNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
NASDAQ
AMZN
Amazon.com
EU
CS
Axa
EU
GLE
Societe Generale
FTSE
UKX
FTSE 100
EU
CAP
Capgemini
USI
USTECH100
US Tech 100
EU
RI
Pernod Ricard
EU
VIV
Vivendi
NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés